Tissue | Expression Dynamics | Abbreviation |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZNF770 | TRANS | Cervix | Healthy | LGALS7,PROK2,BCL2L2, etc. | 6.08e-02 | |
ZNF770 | ICAF | Esophagus | ESCC | SMOX,RP11-576I22.2,SLC8B1, etc. | 2.73e-01 | |
ZNF770 | INCAF | Esophagus | ESCC | SMOX,RP11-576I22.2,SLC8B1, etc. | 2.97e-01 | |
ZNF770 | LC | Lung | Healthy | TIMP3,ELAVL1,TSEN2, etc. | 1.81e-03 | |
ZNF770 | MAST | Lung | MIAC | SOCS4,AC020656.1,FGD2, etc. | 2.11e-01 | |
ZNF770 | MSC.MVA | Oral cavity | ADJ | TUBA4A,SFN,SLPI, etc. | 7.20e-02 | |
ZNF770 | MSC.MVA | Oral cavity | Healthy | TUBA4A,SFN,SLPI, etc. | 6.13e-02 | |
ZNF770 | MSC.MVA | Oral cavity | LP | TUBA4A,SFN,SLPI, etc. | 6.73e-02 | |
ZNF770 | MSC.MVA | Oral cavity | NEOLP | TUBA4A,SFN,SLPI, etc. | 0.00e+00 | |
ZNF770 | FIB | Oral cavity | NEOLP | TUBA4A,SFN,SLPI, etc. | 0.00e+00 | |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF770 | SNV | Missense_Mutation | novel | c.1799N>C | p.Val600Ala | p.V600A | Q6IQ21 | protein_coding | tolerated(0.78) | benign(0) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | rs372474924 | c.263N>A | p.Arg88His | p.R88H | Q6IQ21 | protein_coding | tolerated(0.05) | benign(0.081) | TCGA-A5-A2K3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
ZNF770 | SNV | Missense_Mutation | novel | c.1202N>T | p.Arg401Ile | p.R401I | Q6IQ21 | protein_coding | deleterious(0.01) | benign(0.019) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | | c.750G>T | p.Lys250Asn | p.K250N | Q6IQ21 | protein_coding | deleterious(0.01) | benign(0.012) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | | c.983N>T | p.Arg328Ile | p.R328I | Q6IQ21 | protein_coding | deleterious(0.03) | benign(0.293) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | | c.584N>T | p.Lys195Ile | p.K195I | Q6IQ21 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AP-A0LD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | | c.1841N>T | p.Ser614Leu | p.S614L | Q6IQ21 | protein_coding | tolerated(0.12) | benign(0.001) | TCGA-AP-A0LF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
ZNF770 | SNV | Missense_Mutation | rs575917637 | c.2036G>A | p.Arg679Gln | p.R679Q | Q6IQ21 | protein_coding | tolerated(0.25) | benign(0.001) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ZNF770 | SNV | Missense_Mutation | novel | c.1813G>A | p.Glu605Lys | p.E605K | Q6IQ21 | protein_coding | deleterious(0) | benign(0.062) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ZNF770 | SNV | Missense_Mutation | rs569799193 | c.770G>A | p.Arg257His | p.R257H | Q6IQ21 | protein_coding | tolerated(0.54) | benign(0.374) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |